These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10564)

  • 1. An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.
    Comerford MB; Besterman EM
    Postgrad Med J; 1976 Aug; 52(610):481-6. PubMed ID: 10564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
    Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
    Ekelund LG; Olsson AG; Orö L; Rössner S
    Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Rydén L
    Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metoprolol in angina pectoris].
    Weintraub M; Rabinovitz B; Glaziewski V; Neufeld HN
    Harefuah; 1981 Apr; 100(8):367-9. PubMed ID: 7274804
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
    Keyriläinen O; Uusitalo A
    Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

  • 16. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group.
    Emanuelsson H; Egstrup K; Nikus K; Ellström J; Glud T; Pater C; Scheibel M; Tisell A; Tötterman KJ; Forsby M
    Am Heart J; 1999 May; 137(5):854-62. PubMed ID: 10220634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl)].
    Tomei G; Mosti G; Veltri M; Giusti C
    G Ital Cardiol; 1978; 8(12):1286-92. PubMed ID: 367865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.